Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging

Overview of attention for article published in Acta Neuropathologica Communications, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 4 tweets from 4 users, with an upper bound of 5,371 followers.

RT @citometria: Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from…http:/…

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from…http://t.co/0fc1wK9gGM

A very interesting article on GC TOF MS and Alzheimer's disease "...to discriminate clinical AD participants..." http://t.co/GLFSM1BxYy

CSF study investigates #biomarkers to distinguish DAT from control and finds two metabolite candidates http://t.co/FdzIwoyLfZ

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.